AN2 Therapeutics, Inc. (ANTX)

NASDAQ

$3.56

$-0.09

(-2.47%)

Previous Close: ⁦$3.64⁩

Market Closed

AN2 Therapeutics, Inc. (ANTX) Live Price Chart

Last updated: ⁦2026-10-24 08:37:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

AN2 Therapeutics, Inc. (ANTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.56, with a market capitalization of $137.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $7.19. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$137.36M
Open	$3.61
Day's High	$64.78
Day's Low	$0.87
Previous Close	$3.64
Volume	102.58K
Average Volume	254.52K
P/E Ratio	--
52-Week High	$7.19
52-Week Low	$1.00
Dividend Yield	--
Earnings Date	--

AN2 Therapeutics, Inc. (ANTX) Latest Closing Stock Price

AN2 Therapeutics, Inc. (ANTX) last closed at $3.64 as of 2026-10-23 23:31:00, unchanged from the previous close of $3.64.

During the latest regular trading session, ANTX traded between $0.87 and $64.78, with a volume of 102.58K shares. The closing price was near the lower end and near the middle of its 52-week range.

AN2 Therapeutics, Inc. (ANTX) 7-Day Stock Price Change

Over the past seven days, AN2 Therapeutics, Inc. (ANTX) moved from $3.60 to $3.56, representing a decline of 1.25% ($0.04).

The stock traded between $3.21 and $3.78 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 205.04 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ANTX 52-Week Price Position

Position in Range: 41.3%

52W Low$1.00

52W High$7.19

ANTX is currently trading at $3.56, placing it 41.3% of the way from its 52-week low of $1.00 to its 52-week high of $7.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AN2 Therapeutics, Inc. (ANTX)?

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

AN2 Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	21
Exchange	NASDAQ
Company Website	https://www.an2therapeutics.com

How to Buy AN2 Therapeutics, Inc. (ANTX) Stock on MEXC

Eligible investors can buy real shares of AN2 Therapeutics, Inc. (ANTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ANTX and Place Your Order

Open the RealStocks trading page and search for ANTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AN2 Therapeutics, Inc. (ANTX) stock price today?

AN2 Therapeutics, Inc. (ANTX) is currently trading at $ 3.56, down 2.34% ($0.08) from the previous close of $ 3.64. Intraday prices update in real time during regular trading hours.

2.Is ANTX stock going up or down today?

As of 2026-10-23 23:31:00, ANTX is trading at $ 3.56, down 2.34% ($0.08) from its previous close of $ 3.64. The stock has traded between $ 0.87 and $ 64.78 during today’s regular session. Past price movements do not guarantee future results.

3.What is ANTX pre-market price?

As of 2026-10-23 23:31:00, ANTX is trading at $ 3.67 in pre-market trading, up 0.80% ($0.03) from the previous close of $ 3.64. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ANTX after-hours price?

As of 2026-10-23 23:31:00, ANTX is trading at $ 3.56 in after-hours trading, down 2.34% ($0.08) from the regular-session close of $ 3.64. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ANTX stock trading now?

ANTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ANTX sit relative to its 52-week high and low?

Over the past 52 weeks, ANTX has traded between a low of $ 1.00 and a high of $ 7.19. At $ 3.56, the stock is positioned 41.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AN2 Therapeutics, Inc. in?

AN2 Therapeutics, Inc. (ANTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AN2 Therapeutics, Inc.'s market capitalization and where is it listed?

AN2 Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 137.36M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ANTX valued in terms of P/E ratio and EPS?

ANTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.96. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AN2 Therapeutics, Inc. pay a dividend?

AN2 Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.